Logos Global Management LP, 10% Owner at Dyne Therapeutics, Inc. (DYN), bought 1,504,392 shares at $19.00 ($13.3M) on 2020-09-21, disclosed to the SEC on 2020-09-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 804,392 | $0 | 0.0% |
| 2 | $19.00 | 700,000 | $13.3M | 100.0% |
| Total | $8.84 avg | 1,504,392 | $13.3M | 100% |
| Filing → |
| NVUS | SELL | 2020-11-06 | $690K | — | Filing → |